MyFinsight
Home
Blog
About
Property and equipment,
gross
$83,700K
(21.64%↑ Y/Y)
Accounts receivable, net
and contract assets
$455,827K
(44.09%↑ Y/Y)
Cash and cash
equivalents
$163,138K
(163.72%↑ Y/Y)
Inventories
$137,135K
(-24.45%↓ Y/Y)
Prepaid expenses and
other current assets
$109,059K
(42.28%↑ Y/Y)
Marketable securities,
available-for-sale
$67,865K
(-86.05%↓ Y/Y)
Subtotal
$49,764K
(25.66%↑ Y/Y)
Right of use of assets
$34,507K
(8.11%↑ Y/Y)
Accumulated depreciation
and amortization
$33,936K
(16.19%↑ Y/Y)
Total current assets
$933,024K
(-16.89%↓ Y/Y)
Intangible assets, net
$922,443K
(151.82%↑ Y/Y)
Goodwill
$581,732K
(39.56%↑ Y/Y)
Property and equipment,
net
$84,271K
(17.83%↑ Y/Y)
Prepaid expenses and
other assets
$55,090K
(-2.27%↓ Y/Y)
Restricted cash
$848K
Total assets
$2,577,408K
(25.49%↑ Y/Y)
Total liabilities and
stockholders equity
$2,577,408K
(25.49%↑ Y/Y)
Total liabilities
$2,433,865K
(41.41%↑ Y/Y)
Total stockholders
equity
$143,543K
(-56.86%↓ Y/Y)
Accumulated other
comprehensive loss
-$7,830K
(72.43%↑ Y/Y)
Long-term debt, net
$1,937,684K
(28.40%↑ Y/Y)
Total current
liabilities
$344,439K
(156.50%↑ Y/Y)
Other long-term
liabilities
$102,681K
(32.03%↑ Y/Y)
Deferred tax
liabilities, net
$49,061K
Retained earnings
$151,259K
(-58.10%↓ Y/Y)
Common stock - 0.001 par
value 300,000 shares...
$114K
(-3.39%↓ Y/Y)
Current portion of
long-term debt, net
$208,970K
Accrued expenses
$111,861K
(-3.23%↓ Y/Y)
Accounts payable
$23,608K
(26.31%↑ Y/Y)
Back
Back
Balance Sheet
HALOZYME THERAPEUTICS, INC. (HALO)
HALOZYME THERAPEUTICS, INC. (HALO)
source: myfinsight.com